Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PROCEPT BioRobotics CorpPRCT · Entity 4831 | EVP, Chief Technology Officer | September 09, 2026 | September 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PROCEPT BioRobotics Corp
Report date September 09, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 94,826 |
Reported balance
After 2026-09-09 transaction · row 1
1 source rowRow 1 · 2026-09-09 · Sale · Disposed 373 · Balance 94,826 F1: The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2026 Filed Sep 10, 2026 20:44 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 373 | $20.95 | $7,815.47 |
DisclosureSEC source: 0001588978-26-000032 · wk-form4_1789073060.xml · nonDerivative · entry 1 Templin Barry L · CIK 0002132820 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,826 F1 · kind: The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026. Read SEC document |
| August 13, 2026 Filed Aug 14, 2026 20:35 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 36,312 | $0.00 Strike: $21.95 | $0.00 |
DisclosureSEC source: 0001628280-26-057163 · wk-form4_1786739735.xml · derivative · entry 2 Templin Barry L · CIK 0002132820 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,312 Underlying: Common Stock · 36,312 shares Expires 2036-08-12 F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of August 13, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. The grant is intended to be 50% of the value of the Reporting Person's expected 2027 grant, and made in lieu of such portion of the expected 2027 grant. Read SEC document |
| August 13, 2026 Filed Aug 14, 2026 20:35 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 26,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-057163 · wk-form4_1786739735.xml · nonDerivative · entry 1 Templin Barry L · CIK 0002132820 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,199 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on August 13, 2027, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. The grant is intended to be 50% of the value of the Reporting Person's expected 2027 grant, and made in lieu of such portion of the expected 2027 grant. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:15 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 358 | $28.48 | $10,195.48 |
DisclosureSEC source: 0001628280-26-042213 · wk-form4_1781122525.xml · nonDerivative · entry 1 Templin Barry L · CIK 0002132820 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,953 F1 · shares: The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on June 5, 2026. F2 · balance_after: Includes 860 shares acquired on May 14, 2026, under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.